Global Travel Media » Blog Archive » Coronavirus (COVID-19) Update: Daily Roundup

Home » Coronavirus (Covid-19) » Currently Reading:

Coronavirus (COVID-19) Update: Daily Roundup

March 26, 2020 Coronavirus (Covid-19) No Comments Email Email


Today, the U.S. Food and Drug Administration took the following actions in our ongoing response effort to the COVID-19 pandemic:

The FDA issued a safety alert for fecal microbiota transplantation (FMT) procedures. The FDA has issued a safety communication about the potential for transmission of the COVID-19 virus through FMT, a procedure that delivers human donor stool into the colon of a patient to treat c. difficile infection in patients that have not responded to standard therapies.

The FDA also updated its recommendations regarding specimen collection for COVID-19 testing. Based on available data, FDA believes that, for symptomatic patients, nasal swabs could be used that access just the front of the nose rather than the depth of the nasal cavity. This would provide COVID-19 testing that is more comfortable for patients, allows self-collection of specimens at collection sites, and that can be performed with a simpler and more readily available swab.

The FDA Oncology Center of Excellence issued a message recognizing that patients with cancer, due to potentially being immunocompromised, are at greater risk of contracting COVID-19, and the Center is working to address critical needs of patients with cancer and their health care providers.

Diagnostics update: In certain emergencies, the FDA can often quickly issue an emergency use authorization for diagnostic tests based on FDA’s rolling review of data and where the request meets certain criteria. In the COVID-19 pandemic, the FDA has worked with more than 160 test developers who have said they will be submitting applications to make tests that detect the virus. To date, 15 emergency use authorizations have been issued for nation-wide use, including two today. Under our laboratory developed test policy during COVID-19, the FDA has been notified by more than 65 laboratories.
“The FDA is doing everything we can to support patients, health care professionals, manufacturers of FDA-regulated products and the public during this pandemic,” said FDA Commissioner Stephen Hahn, M.D. “The FDA is working around the clock to monitor and mitigate emerging coronavirus issues through collaborative efforts with federal partners, international regulators and medical product developers and manufacturers to help advance response efforts to combat the COVID-19 outbreak.”



Comment on this Article:







Time limit is exhausted. Please reload CAPTCHA.

Platinium Partnership

ADVERTISEMENTS

Elite Partnership Sponsors

ADVERTISEMENTS

Premier Partnership Sponsors

ADVERTISEMENTS

Official Media Event Partner

ADVERTISEMENTS

Global travel media endorses the following travel Publication

ADVERTISEMENTS

GLOBAL TRAVEL MEDIA VIDEOS

ADVERTISEMENTS

%d bloggers like this:
%d bloggers like this:
sitemap